Indicators

Markets:

News

Latest News about LLY

Recent news which mentions LLY

...

26 27 28 29 30 31 32 33 Next >

Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades

October 05, 2024

Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages

October 04, 2024

Evaluating Eli Lilly Against Peers In Pharmaceuticals Industry

October 04, 2024

England's NHS Proposes Phased Rollout of Eli Lilly's Mounjaro, Considers Digital Services to Boost Access

October 04, 2024

Massive News for Hims & Hers Stock: The Truth About Today's Move

October 04, 2024

Texas Attorney General Sues Insulin Manufacturers and Pharmacy Benefit Managers Over Price-Fixing Conspiracy That Increased Prices by 1,000%

October 03, 2024

Cracking The Code: Understanding Analyst Reviews For Eli Lilly

October 03, 2024

Popular Weight Loss Drugs Like Ozempic Show Gap Between Clinical Trial Promises And Real-World Use, Study Reveals

October 03, 2024

Hims & Hers Health Stock Is Tumbling Thursday: Here's Why

October 03, 2024

This IPO Biotech Stock Could Be the Next Eli Lilly

October 03, 2024

Tandem Diabetes Insulin Pump Demand to Surge Despite Popular Demand Of Weight Loss Drugs, Bullish Analyst Says

October 02, 2024

Eli Lilly Commits $4.5B To New Facility, Banking On Mounjaro, Zepbound's Weight Loss Success Despite Short-Term Stock Challenges

October 02, 2024

Eli Lilly Invests $4.5B In New Medicine Foundry for Advanced Drug Manufacturing To Push US Pharma Boundaries

October 02, 2024

Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation

October 02, 2024

US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next

October 01, 2024

Eli Lilly's Options: A Look at What the Big Money is Thinking

October 01, 2024

Eli Lilly Eyes New Trials For Weight-Loss Drugs In Non-Obese Patients

October 01, 2024

Eli Lilly Aims To Expand Weight-Loss Drug Trials To Those At Risk, Not Just Overweight

October 01, 2024

Tradepulse Power Inflow Alert: Eli Lilly And Company Climbs 15 Points

September 30, 2024

Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate

September 30, 2024

Roche Fast-Tracks Obesity Drug Development, Eyes Over $3B Sales Potential

September 30, 2024

This Is the Best Pharma Stock to Invest $1,000 in Right Now

September 29, 2024

Success in This New Battleground Could Make Eli Lilly and Novo Nordisk Stock Absolutely Fly for Years

September 28, 2024

1 Unstoppable Growth Stock Heading to $2 Trillion by 2030

September 28, 2024

Got $1,000? 2 Superior Growth Stocks to Buy and Hold Forever

September 28, 2024

Prediction: Eli Lilly Will Dominate the Billion-Dollar Weight Loss Drug Market for This Key Reason

September 27, 2024

Novo Nordisk's $600 Million Gambit Could Be a Game Changer for the Stock. Here's Why.

September 26, 2024

Eli Lilly Stock Soars In 2024 On Weight Loss Drug Success, Now The Company Wants Medical Records Of Copycat Treatments

September 25, 2024

Popular Ozempic May Have New Use As Semaglutide Drugs Linked To Reduced Overdose Risk In Diabetic Opioid Users

September 25, 2024

Can Novo Nordisk's Weight Loss Drug Ozempic Help Stem The Devastating Addiction Crisis? New Research Says Yes

September 25, 2024

...

26 27 28 29 30 31 32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.